Bioregenx (BRGX) Other Gross PP&E Adjustments (2024 - 2025)
Bioregenx's quarterly Other Gross PP&E Adjustments came in at -$762000.0 in Q4 2025, up 29.57% year-on-year from -$588077.0 in Q4 2024, and up 29.57% quarter-over-quarter from -$1.1 million in Q4 2024.
Bioregenx has reported Other Gross PP&E Adjustments for 2 years, with the latest figure at -$762000.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments rose 29.57% year-over-year to -$762000.0; the trailing twelve-month figure through Mar 2026 stood at -$762000.0 (up 71.76% YoY), and the FY2025 full-year result was -$762000.0, up 29.57% from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 stood at -$762000.0, up from -$1.1 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was -$614014.0 in Q3 2024, with the low at -$2.2 million in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | -54.30 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | -173.33 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 6.94 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 25.09 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 32.85 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 153.49 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 323.15 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -17.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 289.75 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -762,000.00 |
| Dec 31, 2025 | -762,000.00 |
| Dec 31, 2024 | -1.08 Mn |
| Dec 31, 2024 | -1.08 Mn |
| Sep 30, 2024 | -614,014.00 |
| Sep 30, 2024 | -614,014.00 |
| Jun 30, 2024 | -1.00 Mn |
| Jun 30, 2024 | -1.00 Mn |
| Mar 31, 2024 | -2.20 Mn |
| Mar 31, 2024 | -2.20 Mn |